Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Insights, Forecast to 2028

Market Analysis and Insights: Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market
Due to the COVID-19 pandemic, the global Human Immunodeficiency Virus (HIV) Rapid Test Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Rapid Immunoassay Test accounting for % of the Human Immunodeficiency Virus (HIV) Rapid Test Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Human Immunodeficiency Virus (HIV) Rapid Test Kits market size is valued at US$ million in 2021, while the US and Europe Human Immunodeficiency Virus (HIV) Rapid Test Kits are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Human Immunodeficiency Virus (HIV) Rapid Test Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Human Immunodeficiency Virus (HIV) Rapid Test Kits include Roche, Siemens, Danaher, Abbott Laboratories, Bio-Rad Laboratories, AccuBioTech, BioMerieux, Qiagen and Meridian Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Human Immunodeficiency Virus (HIV) Rapid Test Kits capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Human Immunodeficiency Virus (HIV) Rapid Test Kits by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Scope and Segment
Human Immunodeficiency Virus (HIV) Rapid Test Kits market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Immunodeficiency Virus (HIV) Rapid Test Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Rapid Immunoassay Test
Rapid Molecular Diagnostic Test
Segment by Application
Hospitals
Clinics
Government Organizations
By Company
Roche
Siemens
Danaher
Abbott Laboratories
Bio-Rad Laboratories
AccuBioTech
BioMerieux
Qiagen
Meridian Bioscience
Hologic
Creative Diagnostics
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E